152 related articles for article (PubMed ID: 37718783)
21. Coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma: the influence of lymph node metastasis.
Kim SS; Lee BJ; Lee JC; Kim SJ; Jeon YK; Kim MR; Huh JE; Mok JY; Kim BH; Kim YK; Kim IJ
Head Neck; 2011 Sep; 33(9):1272-7. PubMed ID: 21837696
[TBL] [Abstract][Full Text] [Related]
22. A novel approach to quantify calcifications of thyroid nodules in US images based on deep learning: predicting the risk of cervical lymph node metastasis in papillary thyroid cancer patients.
Wang J; Dong C; Zhang YZ; Wang L; Yuan X; He M; Xu S; Zhou Q; Jiang J
Eur Radiol; 2023 Dec; 33(12):9347-9356. PubMed ID: 37436509
[TBL] [Abstract][Full Text] [Related]
23. A retrospective study of papillary thyroid carcinoma: Hashimoto's thyroiditis as a protective biomarker for lymph node metastasis.
Wang Y; Zheng J; Hu X; Chang Q; Qiao Y; Yao X; Zhou X
Eur J Surg Oncol; 2023 Mar; 49(3):560-567. PubMed ID: 36404253
[TBL] [Abstract][Full Text] [Related]
24. [Clinical research and surgical treatment of Hashimoto's disease complicated with papillary thyroid carcinoma].
Chen Z; Dong HH; Ye Z
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 30(7):532-534. PubMed ID: 29871062
[No Abstract] [Full Text] [Related]
25. Related factor analysis for predicting large-volume central cervical lymph node metastasis in papillary thyroid carcinoma.
Tan L; Ji J; Sharen G; Liu Y; Lv K
Front Endocrinol (Lausanne); 2022; 13():935559. PubMed ID: 36046785
[TBL] [Abstract][Full Text] [Related]
26. Clinical analysis of Hashimoto thyroiditis coexistent with papillary thyroid cancer in 1392 patients.
Liang J; Zeng W; Fang F; Yu T; Zhao Y; Fan X; Guo N; Gao X
Acta Otorhinolaryngol Ital; 2017 Oct; 37(5):393-400. PubMed ID: 29165434
[TBL] [Abstract][Full Text] [Related]
27. Clinical features of multifocal papillary thyroid carcinoma and risk factors of cervical metastatic lymph nodes.
Ni Y; Wang T; Wang X; Tian Y; Wei W; Liu Q
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 51(2):225-232. PubMed ID: 36161301
[TBL] [Abstract][Full Text] [Related]
28. Predictors and a Prediction Model for Central Cervical Lymph Node Metastasis in Papillary Thyroid Carcinoma (cN0).
Gao X; Luo W; He L; Cheng J; Yang L
Front Endocrinol (Lausanne); 2021; 12():789310. PubMed ID: 35154002
[TBL] [Abstract][Full Text] [Related]
29. Clinical features and imaging examination assessment of cervical lymph nodes for thyroid carcinoma.
Wei B; Yao J; Peng C; Zhao S; Wang H; Wang L; Zhu X; Kong Y; Chen L; Xu D
BMC Cancer; 2023 Dec; 23(1):1225. PubMed ID: 38087256
[TBL] [Abstract][Full Text] [Related]
30. A nomogram based on ultrasound characteristics to predict large-number cervical lymph node metastasis in papillary thyroid carcinoma.
Zhang M; Zhang Y; Qiu Y; Wei H; Lyu S
Endocr J; 2023 May; 70(5):481-488. PubMed ID: 36740255
[TBL] [Abstract][Full Text] [Related]
31. Lymph node metastasis of papillary thyroid carcinoma in the context of Hashimoto's thyroiditis.
Wang L; Chen J; Yuan X; Wang J; Sun L; Jiang J; Zhang L; Liu M; Zhou Q
BMC Endocr Disord; 2022 Jan; 22(1):12. PubMed ID: 34986823
[TBL] [Abstract][Full Text] [Related]
32. Nomogram for predicting skip metastasis in cN0 papillary thyroid cancer patients at increased risk of lymph node metastasis.
Li F; Zhou FJ; Zhu TW; Qiu HL; Zhang XT; Ruan BW; Huang DY
Adv Clin Exp Med; 2023 Jul; 32(7):753-761. PubMed ID: 36603142
[TBL] [Abstract][Full Text] [Related]
33. Clinical prediction models for cervical lymph node metastasis of papillary thyroid carcinoma.
Luo S; Lai F; Liang R; Li B; He Y; Chen W; Zhang J; Li X; Xu T; Hou Y; Liu Y; Long J; Yang Z; Chen X
Endocrine; 2024 May; 84(2):646-655. PubMed ID: 38175390
[TBL] [Abstract][Full Text] [Related]
34. Nomogram model based on preoperative serum thyroglobulin and clinical characteristics of papillary thyroid carcinoma to predict cervical lymph node metastasis.
Chang Q; Zhang J; Wang Y; Li H; Du X; Zuo D; Yin D
Front Endocrinol (Lausanne); 2022; 13():937049. PubMed ID: 35909521
[TBL] [Abstract][Full Text] [Related]
35. Preoperative prediction of central lymph node metastasis in cN0T1/T2 papillary thyroid carcinoma: A nomogram based on clinical and ultrasound characteristics.
Li J; Sun P; Huang T; Li L; He S; Ai X; Xiao H; Xue G
Eur J Surg Oncol; 2022 Jun; 48(6):1272-1279. PubMed ID: 35414404
[TBL] [Abstract][Full Text] [Related]
36. The study of the coexistence of Hashimoto's thyroiditis with papillary thyroid carcinoma.
Zhang Y; Dai J; Wu T; Yang N; Yin Z
J Cancer Res Clin Oncol; 2014 Jun; 140(6):1021-6. PubMed ID: 24619663
[TBL] [Abstract][Full Text] [Related]
37. A radiomics nomogram for the ultrasound-based evaluation of central cervical lymph node metastasis in papillary thyroid carcinoma.
Wen Q; Wang Z; Traverso A; Liu Y; Xu R; Feng Y; Qian L
Front Endocrinol (Lausanne); 2022; 13():1064434. PubMed ID: 36531493
[TBL] [Abstract][Full Text] [Related]
38. Risk factor analysis and prediction model for papillary thyroid carcinoma with lymph node metastasis.
Lu J; Liao J; Chen Y; Li J; Huang X; Zhang H; Zhang B
Front Endocrinol (Lausanne); 2023; 14():1287593. PubMed ID: 38027220
[TBL] [Abstract][Full Text] [Related]
39. Construction and validation of a nomogram for predicting cervical lymph node metastasis in diffuse sclerosing variant of papillary thyroid carcinoma.
Lin X; Huo J; Zhang H; Su H; Zhang F
Langenbecks Arch Surg; 2023 Dec; 409(1):8. PubMed ID: 38095691
[TBL] [Abstract][Full Text] [Related]
40. Predicting papillary thyroid carcinoma cervical lymph node metastases: an algorithm using the American College of Radiology Thyroid Imaging, Reporting and Data System.
Shangguan R; Kan G; Yang J; Bao L
Acta Radiol; 2023 Jan; 64(1):101-107. PubMed ID: 34989248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
